Sofinnova Investments, Inc.

Q1 2024 13F Holdings Report, Restatement, Options Holdings

Signature - Title
Nathalie Auber - Attorney-in-Fact
Location
Menlo Park, CA
Options holdings as of
March 31, 2024
Notional value $
$101M
Number of holdings
5
Date filed
8/14/2024, 02:30 PM
Description
All US holdings of this investor are reported in this report.
Previous filing
Q4 2023 - Aug 15, 2024
Next filing
Q2 2024 - Aug 9, 2024
Stock holdings
Showing options holdings, see here for stock holdings
Sym Company Class Option Share Change Activity * Price $ Shares Notional Value
Filing 2024 Q1 - Restatement compared to 2023 Q4 - Restatement by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Nathalie Auber Attorney-in-Fact Menlo Park, California 8/14/2024

*Sofinnova Investments, Inc. is filing this Form 13F on behalf of itself and the general partner entities of the investment funds for which it serves as the investment adviser, Sofinnova Management VII, L.L.C., Sofinnova Management VIII, L.L.C., Sofinnova Management IX, L.L.C., Sofinnova Management X, L.L.C., Sofinnova BioEquities GP LLC, and Sofinnova Synergy GP LLC.